ArticleOPEN ACCESS

Mutation associations in RA-defiant APL

Blood
DOI: 10.1182/blood-2012-07-441303
2Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

One-quarter of acute promyelocytic leukemia (APL) patients develop resistance to all-trans retinoic acid (ATRA)/chemotherapy (CT). In this issue of Blood, Gallagher et al report the associations of PML-RARα mutations, FLT3 mutations, and additional chromosome abnormalities (ACAs) in relapsed APL.

Cite

CITATION STYLE

APA

Chen, S. J. (2012, September 6). Mutation associations in RA-defiant APL. Blood. American Society of Hematology. https://doi.org/10.1182/blood-2012-07-441303

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free